Yasir B. Al-Wakeel - Jul 25, 2022 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Financial Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4
Date filed
7/27/2022, 06:22 PM
Previous filing
Jul 8, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +53.6K +32.83% $0.00 217K Jul 25, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jul 25, 2022 Common Stock 40K $5.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023.